Literature DB >> 18255236

Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion.

D Amantea1, M T Corasaniti, N B Mercuri, G Bernardi, G Bagetta.   

Abstract

Matrix metalloproteinases (MMPs) have been implicated in the pathophysiology of ischemic stroke. In particular, the gelatinases MMP-2 and MMP-9 contribute to disruption of the blood-brain barrier and hemorrhagic transformation following ischemic injury. In addition to extracellular matrix degradation, MMPs may directly regulate neuronal cell death through mechanisms that are not completely understood. Here we describe the spatio-temporal distribution of activated MMP-2 and MMP-9 in the brain of rats subjected to 2 h middle cerebral artery occlusion (MCAo) followed by different periods of reperfusion (15 min, 2 h, 6 h and 22 h). By in situ zymography we have observed that gelatinases become activated 15 min and 2 h after the beginning of reperfusion in the ischemic core and penumbra, respectively. In situ zymography signal broadly co-localized with NeuN-positive cells, thus suggesting that proteolysis mainly occurs in neurons. Gelatinolytic activity was mainly detected in cell nuclei, marginally appearing in the cytosol only at later stages following the insult; we did not detect variations in gelatinolysis in the extracellular matrix. Finally, we report that pharmacological inhibition of MMPs by N-[(2R)-2-(hydroxamidocarbonyl-methyl)-4-methylpenthanoyl]-L-tryptophan methylamide (GM6001) significantly reduces brain infarct volume induced by transient MCAo. Taken together our data underscore the crucial role of gelatinases during the early stages of reperfusion and further extend previous observations documenting the detrimental role of these enzymes in the pathophysiology of brain ischemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18255236     DOI: 10.1016/j.neuroscience.2007.12.030

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  25 in total

1.  Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia.

Authors:  Yi Yang; Eduardo Candelario-Jalil; Jeffrey F Thompson; Eloy Cuadrado; Eduardo Y Estrada; Anna Rosell; Joan Montaner; Gary A Rosenberg
Journal:  J Neurochem       Date:  2009-10-15       Impact factor: 5.372

2.  Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons.

Authors:  J W Hill; R Poddar; J F Thompson; G A Rosenberg; Y Yang
Journal:  Neuroscience       Date:  2012-06-16       Impact factor: 3.590

Review 3.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

Review 4.  Implication of matrix metalloproteinases in regulating neuronal disorder.

Authors:  Abhishek Mukherjee; Snehasikta Swarnakar
Journal:  Mol Biol Rep       Date:  2015-01       Impact factor: 2.316

5.  Modulation of RAGE isoforms expression in the brain and plasma of rats exposed to transient focal cerebral ischemia.

Authors:  Rosaria Greco; Diana Amantea; Antonina Stefania Mangione; Francesco Petrelli; Rocco Gentile; Giuseppe Nappi; Fabio Blandini; M Tiziana Corasaniti; Cristina Tassorelli
Journal:  Neurochem Res       Date:  2012-04-19       Impact factor: 3.996

Review 6.  Implication of Hypothalamus in Alleviating Spinal Cord Injury-Induced Neuropathic Pain.

Authors:  Andrew D Crowell; Kevin King; Annika Deitermann; Gurwattan S Miranpuri; Daniel K Resnick
Journal:  Ann Neurosci       Date:  2016-09-09

Review 7.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 8.  Matrix metalloproteinases as therapeutic targets for stroke.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Brain Res       Date:  2015-04-25       Impact factor: 3.252

9.  Inhibition of gelatinase activity reduces neural injury in an ex vivo model of hypoxia-ischemia.

Authors:  C C Leonardo; A A Hall; L A Collier; P E Gottschall; K R Pennypacker
Journal:  Neuroscience       Date:  2009-03-09       Impact factor: 3.590

10.  Timp-3 deficiency impairs cognitive function in mice.

Authors:  Yoshichika Baba; Osamu Yasuda; Yukihiro Takemura; Yasuyuki Ishikawa; Mitsuru Ohishi; Jun Iwanami; Masaki Mogi; Nobutaka Doe; Masatsugu Horiuchi; Nobuyo Maeda; Keisuke Fukuo; Hiromi Rakugi
Journal:  Lab Invest       Date:  2009-10-05       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.